Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis* - Episode 1
Released On
May 9, 2025
Expires On
April 30, 2026
Media Type
Internet
Completion Time
15 minutes
Specialty
Gastroenterology, Hepatology, Pathology, Radiology
Topic(s)
Primary Biliary Cholangitis
Provider Statement
Supported by independent educational grants from Intercept Pharmaceuticals, Inc. and Ipsen Biopharmaceuticals, Inc.
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit™
- Nurses — .25 Nursing Contact Hour
- Pharmacists — .25 Pharmacy Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
Intended for physicians, physician assistants, registered nurses, nurse practitioners and pharmacists who care for patients with PBC.
Program Overview
This enduring video Clinical Clip will highlight the latest advances in PBC presented at the European Association for the Study of the Liver (EASL) Congress, May 7-10, 2025, Amsterdam, the Netherlands.
In this brief video Clinical Clip, Dr. Nancy Reau covers noteworthy presentations, posters, and abstracts from the conference that are of high clinical significance to improve PBC care.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Appraise and summarize key clinical trial and real-world evidence on approved and emerging agents and combinations in the treatment of PBC
- Identify patient subsets that will benefit from recent progress
Faculty
Nancy Reau, MD
Section Chief Professor of Medicine
Richard B. Capps MD, Professorship of Hepatology
Rush University Medical Center
Chicago, Illinois
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Rush University Medical Center and Practice Point Communications. Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Rush University Medical Center designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
Nancy Reau, MD
Research Grant/Investigator: AbbVie, Gilead
Consultant: Arbutus, Gilead, Salix, VIR
Advisor: Arbutus, Gilead, Salix, VIR
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Rush University Medical Center requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
* This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the European Association for the Study of the Liver (EASL) Congress 2025